New York State Common Retirement Fund
IMNM icon

New York State Common Retirement Fund’s Immunome IMNM Stock Holding History

New York State Common Retirement Fund’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784K Buy
37,000
+7,500
+25% +$160K ﹤0.01% 1832
2026
Q1 		$645K Buy
29,500
+6,000
+26% +$134K ﹤0.01% 1817
2025
Q4 		$505K Hold
23,500
– – ﹤0.01% 1961
2025
Q3 		$275K Buy
23,500
+10,800
+85% +$107K ﹤0.01% 2154
2025
Q2 		$118K Hold
12,700
– – ﹤0.01% 2482
2025
Q1 		$85.5K Hold
12,700
– – ﹤0.01% 2584
2024
Q4 		$135K Hold
12,700
– – ﹤0.01% 2472
2024
Q3 		$186K Sell
12,700
-8,100
-39% -$115K ﹤0.01% 2335
2024
Q2 		$252K Buy
+20,800
New +$325K ﹤0.01% 2331
2021
Q3 		– Sell
-17
Closed – – 3437
2021
Q2 		$0 Sell
17
-3,633
-100% -$80.2K ﹤0.01% 3559
2021
Q1 		$124K Sell
3,650
-1,800
-33% -$44.7K ﹤0.01% 2999
2020
Q4 		$53K Buy
+5,450
New +$63.6K ﹤0.01% 3182

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

New York State Common Retirement Fund's IMNM Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Immunome (IMNM) stake by 25% in Q2 2026, buying an estimated $160K and bringing the position to 37,000 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

New York State Common Retirement Fund first reported a position in IMNM in Q4 2020 and has held it in 12 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • New York State Common Retirement Fund held 37,000 shares of Immunome worth $784K as of Q2 2026.
  • New York State Common Retirement Fund bought 7,500 Immunome shares in Q2 2026, an estimated $160K.
  • Immunome made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1832 holding.
  • New York State Common Retirement Fund first reported a position in Immunome in Q4 2020 and has held it in 12 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.